Company

Recipharm

2022

Quick facts

1,828,439

Emissions (ton CO₂e)

1,293.01

Revenue (M USD)

1,414.09

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Recipharm reported a total of 1,828,439 ton CO₂e, and a net revenue of 1,293.01 M USD, resulting in a emissions intensity of 1,414.09 t CO₂e / M USD.

Targets

Base year:

2021

Target year:

2030

Reduction:

0.42

Classification:

1.5°C

Recipharm commits to reduce absolute scope 1 and 2 GHG emissions 42.1% by 2030 from a 2021 base year*. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Revenue	2021	2022
Net Revenue (M USD)	1,210.21	1,293.01
Revenue Source

Emissions Overview	2021	2022
Total Emissions - Market Based (t CO₂e)	1,697,115	1,828,439
Emissions Intensity (t CO₂e / M USD)	1,402.33	1,414.09
Cradle-to-gate Intensity (t CO₂e / M USD)	1,402.33	1,414.09

Emissions Details	2021	2022
Scope 1	80,282	61,189
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based	10,572	15,293
Scope 2 - Not specified
Scope 3	1,606,261	1,751,957
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions	1,697,115	1,828,439
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0